Several studies have reported higher serum and salivary levels of IL-6 in patients with OLP, especially in those with an erosive/atrophic form of the disease, suggesting that this cytokine may be a marker for monitoring the disease [25,30]. This evidence concerns the gene IL6 and oral lichen planus.